BrainTalk

Software for Detecting Cognitive Deficits

Health Tech & Life Sciences
Non Active, Oct 2020 ceased to operate
Follow

Company Overview

Snapshot

Founded in March 2016 by Vadim Kagan, Sari Maril, VS Subrahmanian, and Ayala Bloch, BrainTalk operated with 1–10 employees. The company ceased operations in October 2020.

Business overview

BrainTalk developed a software solution designed for the rapid and accurate detection of cognitive deficits using a five-minute speech sample. Its patent-pending intelligent algorithm was capable of identifying cognitive impairments resulting from stroke, aging, disease, and medical interventions like chemotherapy. The technology aimed to provide health and sports organizations with a non-invasive, cost-effective, and repeatable tool for screening and monitoring large populations with known or suspected brain damage, operating within the Health Tech & Life Sciences sector, specifically digital healthcare and medical diagnostics.

Log in to access full profile

Company Intelligence Q&A

What is BrainTalk's primary offering?
BrainTalk developed a software solution that detects cognitive deficits quickly and accurately based on a five-minute speech sample, utilizing a patent-pending intelligent algorithm.
When was BrainTalk founded?
BrainTalk was founded in March 2016.
Who are the founders of BrainTalk?
BrainTalk was founded by Vadim Kagan, Sari Maril, VS Subrahmanian, and Ayala Bloch.
What was the operational status of BrainTalk?
BrainTalk ceased to operate in October 2020.
What industries or markets did BrainTalk target?
BrainTalk's technology was designed to serve health and sports organizations, providing tools to screen and monitor populations with known or suspected brain damage.
Log in to access full profile